MedCity News August 3, 2021
Consumers and benefits managers have a record number of digital health tools to choose from, according to a new report by the IQVIA Institute for Human Data Science.
As investors pour record amounts of funding into digital health companies, consumers and benefits managers have a growing number of apps to evaluate. A new report by the IQVIA Institute for Human Data Science puts this into numbers.
The report’s authors identified 150 digital therapeutics and digital care products that are commercially available. The former includes software that can be prescribed like medication, such as Akili’s mobile game to improve attention in kids with ADHD, while the latter includes programs to help people manage clinical conditions, such as Omada’s digital diabetes...
Today's Sponsors
Today's Sponsor